VMS stands for vasomotor symptoms, the medical term for hot flashes and night sweats during menopause. These are episodes of sudden, intense heat accompanied by sweating and flushing, concentrated around the head, neck, chest, and upper back. They are the most common and recognizable symptoms of the menopausal transition, affecting up to three out of four women in the first two years after their final period.
What Happens in Your Body During VMS
Your brain has an internal thermostat in a region called the hypothalamus. Normally, this thermostat tolerates a range of body temperatures before triggering cooling responses like sweating or skin flushing. Estrogen helps keep that range wide. As estrogen levels drop during menopause, the range narrows dramatically, so even a tiny increase in core body temperature can trip the alarm. Your body then launches a full cooling response: blood vessels near the skin dilate, sweat glands activate, and you feel a wave of heat and flushing that can last anywhere from a few seconds to several minutes.
A specific group of brain cells, sometimes called KNDy neurons, plays a central role. These neurons release signaling chemicals that are normally kept in check by estrogen. When estrogen withdraws, those signals become overactive and destabilize the thermostat. This is the core mechanism behind every hot flash and night sweat.
How Common VMS Are at Each Stage
VMS don’t arrive all at once. Their prevalence climbs steadily as you move through the menopausal transition. In the late reproductive years, before periods change noticeably, only about 6 to 13% of women report them. During the early transition, when cycles start becoming irregular, that rises to 4 to 46%. By the late transition, when periods are being skipped, 33 to 63% of women experience VMS. After the final menstrual period, prevalence peaks at 41 to 79%.
The wide ranges reflect real differences between individuals. Factors like body weight, smoking history, and race or ethnicity all influence who gets hit hardest and when.
How Long VMS Typically Last
One of the biggest surprises for many women is how long VMS can persist. The median duration of moderate to severe hot flashes is about 10 years. When mild episodes are included, that stretches to nearly 12 years. These are not brief, passing inconveniences for most women.
Timing of onset matters a great deal. Women whose hot flashes begin before age 40 tend to experience them for over 11.5 years. Those starting between 45 and 49 have a median duration of about 8 years. Women whose symptoms don’t appear until age 50 or later tend to have the shortest course, around 3.8 years. In other words, the earlier VMS start, the longer they tend to stick around.
Night Sweats and Sleep Disruption
Night sweats are simply hot flashes that happen during sleep, but their impact goes beyond discomfort. Studies using overnight sleep monitoring show that 54 to 69% of objectively measured nighttime hot flashes are associated with a full awakening. Each episode increases the total time spent awake after initially falling asleep and adds to the number of awakenings throughout the night.
Even when night sweats don’t fully wake you, they can increase the rate of transitions between deeper and lighter sleep stages, fragmenting sleep quality in ways that leave you feeling unrefreshed. Over months and years, this chronic disruption contributes to daytime fatigue, difficulty concentrating, and mood changes that many women attribute to “just getting older” rather than recognizing as a direct consequence of VMS.
VMS and Cardiovascular Risk
Severe VMS appear to be more than a comfort issue. A pooled analysis of six large studies found that women reporting severe hot flashes had an 83% higher risk of cardiovascular disease compared to women without VMS. Severe night sweats were linked to a 59% higher risk. Women who experienced both severe hot flashes and severe night sweats had a 55% higher risk than those with just one type.
The pattern was tied to severity rather than frequency. Having occasional mild hot flashes didn’t carry the same signal. Researchers believe severe VMS may reflect underlying vascular changes, including stiffer arteries and reduced blood vessel flexibility, that independently raise heart disease risk.
Common Triggers That Make VMS Worse
Certain habits and exposures reliably increase the frequency or intensity of hot flashes. The most consistently identified triggers include:
- Smoking: Both current and past smoking raise VMS risk, likely because of smoking’s anti-estrogenic effects. The more cigarettes and the longer the history, the worse the symptoms.
- Higher body weight: Obesity interacts with smoking to amplify VMS risk significantly. A pooled analysis of over 21,000 women found that higher BMI was independently associated with more frequent and severe episodes.
- Alcohol: Drinking three or more times per week was associated with a threefold increase in VMS aggravation in one study of nearly 4,600 women.
- Diets high in fat and sugar: This dietary pattern increased VMS risk by about 23% compared to lower-fat diets.
- Stress: Psychological stress directly increases both the frequency and intensity of hot flashes.
- Spicy foods: These have a positive association with VMS, meaning they tend to trigger or worsen episodes.
Treatment Options
Hormone Therapy
Estrogen-based hormone therapy remains the most effective treatment for VMS. It reduces both the frequency and intensity of hot flashes by roughly 90%, typically within the first month. For women who still have a uterus, a progestogen is added to protect the uterine lining. Hormone therapy isn’t suitable for everyone, particularly women with a history of certain cancers, blood clots, or cardiovascular events, which is why non-hormonal options have become increasingly important.
Non-Hormonal Medications
Several classes of non-hormonal drugs can meaningfully reduce VMS. Certain antidepressants in the SSRI and SNRI families have shown reductions in hot flash frequency ranging from 10 to 65%, depending on the specific medication and dose. One SNRI reduced hot flash frequency by 48%, compared to 53% for estrogen and 29% for placebo, putting it in a comparable range to hormonal treatment for some women.
A newer class of medication works by directly targeting the brain mechanism behind VMS. These drugs block the receptor that KNDy neurons use to destabilize the thermostat, addressing the root cause rather than working through indirect pathways. The first of these was approved by the FDA in 2023 after clinical trials demonstrated significant reductions in both the frequency and severity of hot flashes. This option is particularly relevant for women who cannot or prefer not to use hormones.
Lifestyle Approaches
While lifestyle changes alone are unlikely to eliminate moderate or severe VMS, reducing known triggers can lower the overall burden. Quitting smoking, limiting alcohol, managing stress, and shifting toward a diet lower in saturated fat and added sugar all have supporting evidence. Reducing alcohol has also been shown to improve sleep quality during menopause, even when it doesn’t directly reduce the number of hot flashes. These changes work best as a complement to medical treatment rather than a replacement for it.